Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

BACKGROUND: This study aimed to assess the characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background pain in comparison with patients receiving at least 60 mg of oral morphine equivalents (OME). MATERIALS AND METHODS: Patients with advanced cancer r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Mercadante, Sebastiano, Caraceni, Augusto, Masedu, Francesco, Scipioni, Teresa, Aielli, Federica
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Symptom Management and Supportive Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011660/
https://ncbi.nlm.nih.gov/pubmed/31862860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0542
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars